Skip to Content
Merck

Skip To

P0424

Prostaglandin F2α tris salt

≥99%, synthetic, powder

Synonym(s):

(5Z,9α,11α,13E,15S)-9,11,15-Trihydroxyprosta-5,13-dienoic acid tris salt, PGF2α−Tris

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View
Size/SKUAvailabilityPrice

About This Item

Empirical Formula (Hill Notation):
C20H34O5 · C4H11NO3
CAS Number:
Molecular Weight:
475.62
NACRES:
NA.77
PubChem Substance ID:
eCl@ss:
42020658
UNSPSC Code:
12352401
EC Number:
254-002-3
MDL number:
Beilstein/REAXYS Number:
4087514
Pricing and availability is not currently available.
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


biological source

synthetic

Quality Segment

assay

≥99%

form

powder

color

white

solubility

H2O: 1 mg/mL, ethanol: 50 mg/mL

functional group

carboxylic acid, hydroxyl

shipped in

ambient

storage temp.

−20°C

SMILES string

NC(CO)(CO)CO.[H][C@]1(C\C=C/CCCC(O)=O)[C@@H](O)C[C@@H](O)[C@]1([H])\C=C\[C@@H](O)CCCCC

InChI

1S/C20H34O5.C4H11NO3/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25;5-4(1-6,2-7)3-8/h4,7,12-13,15-19,21-23H,2-3,5-6,8-11,14H2,1H3,(H,24,25);6-8H,1-3,5H2/b7-4-,13-12+;/t15-,16+,17+,18-,19+;/m0./s1

InChI key

IYGXEHDCSOYNKY-RZHHZEQLSA-N

Gene Information

human ... PTGFR(5737)

General description

Aqueous solutions are stable for 30 days at 2-8°C and for several months frozen at −0°C in single use aliquots. Avoid repeated freeze/thaw cycles.

Biochem/physiol Actions

Luteolytic prostaglandin that induces parturition. Potent vasoconstrictor of pulmonary, coronary, and cerebral arteriole beds.
Luteolytic prostaglandin that induces parturition. Potent vasoconstrictor of pulmonary, coronary, and cerebral arteriole beds. A positive feedback loop between endometrial PG F2α and luteal oxytocin is responsible for completion of luteolysis.
Luteolytic prostaglandin that induces parturition. Potent vasoconstrictor of pulmonary, coronary, and cerebral arteriole beds. Also stimulates contraction of smooth muscle, such as in bronchi, with possible involvement in asthma. This effect is at least partially mediated through tachykinin release.

Compare Similar Items

View Full Comparison

Show Differences

1 of 1

This Item
1213001P5069D2255000
description

≥99%, synthetic, powder

description

United States Pharmacopeia (USP) Reference Standard

description

synthetic, suitable for cell culture

description

European Pharmacopoeia (EP) Reference Standard

functional group

hydroxyl, carboxylic acid

functional group

-

functional group

-

functional group

-

assay

≥99%

assay

-

assay

≥99%

assay

-

biological source

synthetic

biological source

-

biological source

synthetic

biological source

-

storage temp.

−20°C

storage temp.

2-8°C

storage temp.

−20°C

storage temp.

-

form

powder

form

-

form

powder

form

-

shipped in

ambient

shipped in

-

shipped in

ambient

shipped in

-


Still not finding the right product?

Explore all of our products under Prostaglandin F2α tris salt


Pictograms

Health hazardExclamation mark

Signal Word

Danger

Hazard Codes

Hazard Classifications

Acute Tox. 4 Oral - Repr. 1B

Storage Class

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

WGK

WGK 3

PPE (personal protective equipment)

Eyeshields, Gloves, type P3 (EN 143) respirator cartridges



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library




Questions

Reviews

No rating value

Active Filters